Respiratory Infections News

Nearly 15 million people died as a direct or indirect result of COVID-19 during the first 24 months of the pandemic, according to a new estimate published Thursday by WHO.

A randomized controlled trial in India demonstrated that 12 months of oral itraconazole was superior to a 6-month regimen in reducing relapses of chronic pulmonary aspergillosis, researchers reported in The Lancet Infectious Diseases.

DENVER — The interleukin-1 inhibitor anakinra has little to no effect on moderate to severe multisystem inflammatory syndrome in children, according to researchers.

Researchers estimated that more than 200 million people globally suffer from long-term effects of COVID-19, according to a recent study.

CHICAGO — Although questions remain regarding SARS-CoV-2, including the number of boosters a person will eventually require and how to manage patients with long COVID, physicians have learned a lot about the virus.

Moderna announced today that it has submitted a request to the FDA to authorize its COVID-19 vaccine in children aged as young as 6 months.

DENVER — A study of immunocompromised children found that most mounted an immune response after two doses of COVID-19 vaccine, which increased modestly after a third dose, researchers reported at the Pediatric Academic Societies Meeting.

LISBON, Portugal — In this video, Luke B. Snell, MD, MSc, MBBS, from Guy’s and St. Thomas’ NHS Foundation Trust in London, explains the case of a patient who tested positive for SARS-CoV-2 for 505 consecutive days — thought to be a record.

LISBON, Portugal — A study conducted among health care workers in the United Kingdom demonstrated that longer intervals between COVID-19 vaccine doses produced higher antibody levels, researchers reported here.

LISBON, Portugal — The average number of daily COVID-19 deaths is 6% higher on weekends compared with weekdays, according to a global study presented at the European Congress of Clinical Microbiology and Infectious Diseases.